GO:0043190 ATP-binding cassette (ABC) transporter complex: Components, Assembly and Research Methods, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0043190 describes the ATP-binding cassette (ABC) transporter complex, a cellular component typically composed of two membrane-associated domains and two ATP-binding domains that form a central pore for metabolite transport.
ABC transporter complexes are found in all domains of life and are encoded by one of the largest gene superfamilies, with 48 human ABC genes identified.
In bacteria and archaea, ABC transporters additionally include substrate-binding proteins that deliver substrates to the transporter.
ABC transporters are involved in diverse physiological processes including multidrug resistance, lipid homeostasis, and ion transport.
Dysfunction of ABC transporters is linked to diseases such as cystic fibrosis, Tangier disease, and cancer drug resistance.
CRISPR-based methods enable precise knockout, point mutation, knock-in, and overexpression of ABC transporter genes for functional studies.

Description

The ATP-binding cassette (ABC) transporter complex (GO:0043190) is a fundamental cellular component responsible for the ATP-dependent transport of a wide variety of substrates across biological membranes. These complexes are ubiquitous, found in bacteria, archaea, and eukaryotes, and constitute one of the largest protein superfamilies. In humans, 48 ABC genes have been identified, many of which are associated with inherited diseases and drug resistance. Understanding the structure, function, and regulation of ABC transporter complexes is therefore critical for basic biology and clinical research. This article provides a comprehensive overview of GO:0043190, integrating authoritative QuickGO data with verified PubMed literature to support researchers studying these complexes.

ATP-binding cassette (ABC) transporter complex At A Glance

GO ID GO:0043190
GO term ATP-binding cassette (ABC) transporter complex
Ontology cellular_component
Synonym ABC-type efflux permease complex, ABC-type efflux porter complex, ABC-type uptake permease complex, mating pheromone exporter
Major function ATP-dependent transport of metabolites into and out of the cell
Domain composition Typically two membrane-associated domains and two ATP-binding domains
Additional components Substrate-binding proteins in Bacteria and Archaebacteria
Cellular location Plasma membrane (central pore through membrane)

What Is GO:0043190?

The ATP-binding cassette (ABC) transporter complex is a molecular machine that uses ATP hydrolysis to pump metabolites into and out of cells. According to the Gene Ontology, it typically comprises four core domains: two membrane-associated domains that form the translocation pathway and two ATP-binding domains located at the intracellular face of the membrane. These domains assemble into a central pore through the plasma membrane. In bacteria and archaea, the complex also includes substrate-binding proteins that capture substrates outside the cytoplasm and deliver them to the transporter. The four domains can be encoded as separate polypeptides or fused in various combinations into multidomain proteins.

Why Is ATP-binding cassette (ABC) transporter complex Important in Cell Biology?

ABC transporter complexes are essential for numerous cellular processes, including nutrient uptake, toxin efflux, and signal transduction. Their dysfunction is implicated in a wide range of human diseases, from cystic fibrosis to cancer multidrug resistance. Moreover, bacterial ABC transporters are key players in antibiotic resistance and virulence, making them attractive targets for new antimicrobial therapies. Studying these complexes provides insights into fundamental membrane transport mechanisms and offers opportunities for therapeutic intervention.
ABC transporters are involved in multidrug resistance in cancer cells, limiting chemotherapy efficacy.
Mutations in ABC transporter genes cause diseases such as cystic fibrosis (ABCC7/CFTR), Tangier disease (ABCA1), and Stargardt disease (ABCA4).
Bacterial ABC transporters contribute to antibiotic resistance and are potential drug targets.
ABC transporters play roles in lipid trafficking, ion homeostasis, and immune responses.
They are used as tools in biotechnology for membrane protein production and structural studies.
ABC transporter complexes are studied to understand evolutionary relationships and domain fusion events.
They are implicated in cadmium detoxification and metal transport.
ABC transporters can act as sensory complexes regulating gene expression, as shown for bacitracin resistance.
The CydDC family exemplifies ABC transporters involved in cytochrome assembly and redox homeostasis.

What Happens During ATP-binding cassette (ABC) transporter complex?

Substrate Binding and Delivery
In simple terms: The transporter grabs its cargo and gets ready to move it.
In bacteria and archaea, substrate-binding proteins capture specific substrates in the periplasm or extracellular space and deliver them to the membrane-associated domains of the ABC transporter complex. In eukaryotes, substrates are typically recognized directly by the transmembrane domains. This initial binding ensures specificity and initiates the transport cycle.
ATP Binding and Dimerization
In simple terms: The transporter uses energy from ATP to power the transport.
The two ATP-binding domains (nucleotide-binding domains, NBDs) bind ATP, which induces dimerization of the NBDs and causes conformational changes that are transmitted to the membrane domains. This step is critical for coupling ATP hydrolysis to substrate translocation.
Conformational Change and Substrate Translocation
In simple terms: The transporter changes shape to push the cargo across the membrane.
ATP binding and hydrolysis drive alternating access of the substrate-binding site from one side of the membrane to the other, allowing the substrate to be transported across the lipid bilayer. The membrane domains undergo significant rearrangements to open a pathway for the substrate.
ATP Hydrolysis and Reset
In simple terms: The transporter resets after releasing the cargo.
Hydrolysis of ATP to ADP and inorganic phosphate provides the energy for the transport cycle and leads to dissociation of the NBD dimer, returning the complex to its resting state. This cycle can be repeated many times, allowing continuous transport.

Key Genes Involved in GO:0043190 ATP-binding cassette (ABC) transporter complex

The following genes encode components of ABC transporter complexes across various organisms, with a focus on human and bacterial systems.
GeneMajor RoleResearch Relevance
ABCA1Cholesterol and phospholipid effluxTangier disease, HDL metabolism
ABCB1 (MDR1)Multidrug efflux pumpCancer drug resistance
ABCC7 (CFTR)Chloride channelCystic fibrosis
ABCG2 (BCRP)Uric acid and drug effluxGout, cancer resistance
ABCA4Retinaldehyde transportStargardt disease
ABCB11 (BSEP)Bile salt exportProgressive familial intrahepatic cholestasis
ABCC1 (MRP1)Glutathione conjugate effluxMultidrug resistance
ABCC2 (MRP2)Organic anion transportDubin-Johnson syndrome
ABCG5Sterol effluxSitosterolemia
ABCG8Sterol effluxSitosterolemia
ABCB4 (MDR3)Phosphatidylcholine translocationPFIC3
ABCB6Porphyrin transportDyschromatosis universalis hereditaria
ABCB7Iron-sulfur cluster transportX-linked sideroblastic anemia
ABCC6Nucleotide transportPseudoxanthoma elasticum
ABCC8Sulfonylurea receptorNeonatal diabetes, hyperinsulinism
ABCC9Sulfonylurea receptorDilated cardiomyopathy
ABCA3Surfactant lipid transportNeonatal respiratory distress

How Is ATP-binding cassette (ABC) transporter complex Regulated?

ABC transporter complex activity is regulated at multiple levels, including transcriptional control, post-translational modifications, and interaction with regulatory proteins. For example, the bacitracin resistance ABC transporter in Bacillus subtilis forms a sensory complex with a two-component regulatory system, where the transporter itself senses the substrate and activates a response regulator. Additionally, the CydDC family of ABC transporters is regulated in response to redox state and is involved in cytochrome assembly. In eukaryotes, ABC transporters can be regulated by phosphorylation and membrane trafficking.

ATP-binding cassette (ABC) transporter complex and Human Disease

GeneDisease / BiologyPotential Experimental Model
ABCB1Cancer multidrug resistanceKnockout in cancer cell lines, overexpression
CFTRCystic fibrosisPoint mutation knock-in in iPSCs
ABCA1Tangier diseaseKnockout in hepatocytes, overexpression
ABCA4Stargardt diseaseKnock-in of patient mutations in retinal organoids
ABCC8Neonatal diabetesKnockout in pancreatic beta cells
ABC Transporters in Cancer Multidrug Resistance
Overexpression of ABC transporters such as ABCB1, ABCC1, and ABCG2 leads to efflux of chemotherapeutic drugs from cancer cells, resulting in multidrug resistance and treatment failure. These transporters are therefore major targets for overcoming chemoresistance.
Genetic Disorders Caused by ABC Transporter Mutations
Mutations in ABC transporter genes cause a variety of inherited diseases, including cystic fibrosis (CFTR/ABCC7), Tangier disease (ABCA1), Stargardt disease (ABCA4), and progressive familial intrahepatic cholestasis (ABCB11, ABCB4). These disorders highlight the critical physiological roles of ABC transporters.
Bacterial ABC Transporters and Antibiotic Resistance
In bacteria, ABC transporters contribute to resistance against antibiotics and antimicrobial peptides by actively exporting these compounds. For instance, the bacitracin resistance transporter in Bacillus subtilis is part of a sensory complex that detects bacitracin and triggers a regulatory response.
ABC Transporters in Metal Detoxification
Mammalian ABC transporters can transport toxic metals such as cadmium, contributing to detoxification and cellular protection. Dysregulation of these transporters may influence metal-related toxicity and disease.

From ATP-binding cassette (ABC) transporter complex-Related Genes to Experimental Models

Research QuestionSuitable Model
Does loss of ABCB1 restore drug sensitivity?CRISPR knockout in multidrug-resistant cancer cells
Does a specific CFTR mutation impair chloride transport?Point mutation knock-in in airway epithelial cells
Can ABCA1 overexpression increase cholesterol efflux?Overexpression in macrophages
How does ABCG2 tagging affect its localization?Tagged knock-in in cancer cell lines
What is the role of bacterial ABC transporter in antibiotic resistance?Knockout in Bacillus subtilis
Does ABC transporter inhibition affect cadmium toxicity?Knockout in renal proximal tubule cells

How to Study the ATP-binding cassette (ABC) transporter complex Process

MethodWhat It MeasuresTypical Application
CRISPR knockoutGene function lossDrug resistance studies
Cryo-EM3D structure of transporterMechanistic insights
Transport assaySubstrate efflux/influxFunctional characterization
RNA-seqTranscriptional changesExpression profiling
ProteomicsProtein abundance and interactionsComplex composition
Site-directed mutagenesisSpecific residue functionATP hydrolysis studies
Patch-clampIon channel activityCFTR function
Flow cytometrySurface expression and effluxABCG2 activity
CRISPR-Cas9 Genome Editing
CRISPR-Cas9 is widely used to create knockout, point mutation, knock-in, and overexpression models of ABC transporter genes. These models enable precise dissection of gene function in disease and drug resistance.
Structural Biology (Cryo-EM and X-ray Crystallography)
High-resolution structures of ABC transporter complexes reveal domain organization, substrate binding sites, and conformational changes during the transport cycle.
Transport Assays
Radioactive or fluorescent substrate transport assays measure the activity of ABC transporters in membrane vesicles or intact cells, providing functional validation of genetic models.
Transcriptomics and Proteomics
RNA-seq and quantitative proteomics can assess expression levels of ABC transporters in response to drugs or genetic perturbations, identifying regulatory networks.

How CRISPR Can Be Used to Study GO:0043190 ATP-binding cassette (ABC) transporter complex

Knockout

CRISPR knockout of ABC transporter genes is used to eliminate protein function and study its role in drug resistance, substrate transport, and disease progression. For example, ABCB1 knockout in cancer cells reverses multidrug resistance.

Point Mutation

Point mutations can be introduced to model disease-causing variants, such as CFTR F508del, and to dissect the function of specific residues in ATP binding or substrate recognition.

Knock-in

Knock-in of reporter tags or patient mutations allows visualization of transporter localization and dynamics, as well as study of mutant-specific phenotypes.

Overexpression

Overexpression of ABC transporters via CRISPR activation or cDNA delivery is used to study gain-of-function effects, such as increased drug efflux and resistance.

How EDITGENE Supports ATP-binding cassette (ABC) transporter complex Research

Researchers studying ATP-binding cassette (ABC) transporter complex-related genes often need to determine whether a candidate gene is causally involved in transport, drug resistance, or disease. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for ATP-binding cassette (ABC) transporter complex research.

Frequently Asked Questions About ATP-binding cassette (ABC) transporter complex

It is a cellular component (GO:0043190) that uses ATP to transport metabolites across membranes, typically composed of two membrane domains and two ATP-binding domains.
Genes include ABCA1, ABCB1, ABCC1, ABCG2, CFTR, and many others, each encoding a transporter or its subunits.
They bind substrates, use ATP hydrolysis to drive conformational changes, and translocate substrates across the membrane.
Diseases include cystic fibrosis, Tangier disease, Stargardt disease, and cancer multidrug resistance.
Bacterial ABC transporters export antibiotics and antimicrobial peptides, contributing to resistance.
Use CRISPR knockout, point mutation, knock-in, overexpression, transport assays, and structural biology.
Typically two transmembrane domains and two nucleotide-binding domains; in bacteria, also substrate-binding proteins.
Yes, they are ubiquitous, from bacteria to humans.
ABCB1 (MDR1) overexpression causes multidrug resistance in cancer, limiting chemotherapy efficacy.
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services for ABC transporter genes.

Conclusion

The ATP-binding cassette (ABC) transporter complex (GO:0043190) is a vital cellular machine with broad implications in health and disease. Its structural and functional diversity, coupled with its role in drug resistance and genetic disorders, makes it a prime target for biomedical research. Leveraging CRISPR-based models and advanced methodologies will continue to unravel the complexities of ABC transporters and facilitate therapeutic development.

References

  1. 1. Dean M et al.. 2001. The human ATP-binding cassette (ABC) transporter superfamily.. Genome Res 11(7):1156-66 PMID: 11435397
  2. 2. Younus I et al.. 2022. ATP-Binding Cassette Transporters: Snap-on Complexes?. Subcell Biochem 99:35-82 PMID: 36151373
  3. 3. Dean M et al.. 2005. Evolution of the ATP-binding cassette (ABC) transporter superfamily in vertebrates.. Annu Rev Genomics Hum Genet 6:123-42 PMID: 16124856
  4. 4. Thévenod F et al.. 2024. Cadmium transport by mammalian ATP-binding cassette transporters.. Biometals 37(3):697-719 PMID: 38319451
  5. 5. Bilsing FL et al.. 2023. ABC Transporters in Bacterial Nanomachineries.. Int J Mol Sci 24(7) PMID: 37047196
  6. 6. Efferth T. 2001. The human ATP-binding cassette transporter genes: from the bench to the bedside.. Curr Mol Med 1(1):45-65 PMID: 11899242
  7. 7. Dintner S et al.. 2014. A sensory complex consisting of an ATP-binding cassette transporter and a two-component regulatory system controls bacitracin resistance in Bacillus subtilis.. J Biol Chem 289(40):27899-910 PMID: 25118291
  8. 8. Poole RK et al.. 2019. The CydDC family of transporters.. Res Microbiol 170(8):407-416 PMID: 31279084
Contact Us
*
*
*
*
How did you hear about us: